Pharma marketers must be in a constant state of learning and adaptation. The speed of medical advancement only seems to be outpaced by the speed of information. And this information is placing patients squarely in the driver’s seat when it comes to their health and their healthcare decisions.
Public Relations professionals often debate if the press release is dead. Many people rely on social media as a primary source for news. According to Forbes, 63% of both Facebook and Twitter users receive their news from the social media. Some companies consider this trend as a reason to abandon press releases. And, while announcing news on a social channel may be strategic in some cases, well-written press releases are mainstay for corporate news distribution in 2018.
Mom bloggers, considered among the most valuable Digital Influencers, can be a critical component of your public relations and marketing programs. Mom bloggers are particularly sought-after for healthcare opinion leadership since women and mothers drive most of the household healthcare decisions.
In a global sea of thousands of life science companies, getting lost can be easy. It is vital for corporations to develop and maintain a strong corporate image to ensure long-term business success. And, increasingly in a world of constant connectivity, corporations are delivering messages directly to their target audiences. In a recent Forbes survey of 2,500 U.S. adults, on perceptions of 100 corporate brands, Johnson & Johnson prevailed as number one.
JFK Communication is witnessing a new trend in healthcare. The terms Patient Engagement and Patient Advocacy are being used interchangeably. So, are these two functions different?
We know that CRISPR is an emerging technology that holds the promise of radically changing the way we treat and, potentially, prevent and cure human diseases. We have already seen Biotech companies such as Crispr Therapeutics (CRSP), Intellia Therapeutics (NTLA) and Editas Medicine (EDIT) invest millions of dollars into this technology and pave the way toward countless therapeutic options for many common and rare diseases.
